|
|
|
Insider
Information: |
Zakrzewski Joseph S |
Relationship: |
|
City: |
Bedford |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
647,942 |
|
Indirect Shares
|
554,931 |
|
|
Direct
Value |
$12,596,328 |
|
|
Indirect Value
|
$1,403,952 |
|
|
Total
Shares |
1,202,873 |
|
|
Total
Value |
$14,000,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
21
|
1
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
19
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-40.0%
|
-87.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Insulet Corp |
PODD |
Director |
2017-05-17 |
30,558 |
2008-11-11 |
0 |
Premium* |
|
Amarin Corp Plc |
AMRN |
|
2021-12-15 |
196,547 |
|
0 |
Premium* |
|
Liposcience Inc |
LPDX |
Director |
2014-11-20 |
0 |
2014-06-11 |
0 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
2021-04-01 |
34,499 |
2016-12-30 |
0 |
Premium* |
|
Sangamo Biosciences Inc |
SGMO |
Director |
2022-02-25 |
60,700 |
2018-06-11 |
0 |
Premium* |
|
Cyteir Therapeutics, Inc. |
CYT |
Director |
2024-02-06 |
227,439 |
2024-02-06 |
149,051 |
Premium* |
|
An2 Therapeutics Ord Shs |
ANTX |
|
2024-01-18 |
98,199 |
2024-01-18 |
405,880 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-30 |
4 |
B |
$25.50 |
$102,000 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
5,250 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
6,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
7,750 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2019-06-14 |
4 |
B |
$38.05 |
$190,250 |
D/D |
5,000 |
12,750 |
2.39 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2020-01-07 |
4 |
OE |
$3.88 |
$72,750 |
D/D |
18,750 |
31,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,377 |
32,877 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,622 |
34,499 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2021-04-01 |
4 |
AS |
$132.61 |
$1,346,382 |
D/D |
(10,000) |
34,499 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2021-04-01 |
4 |
OE |
$24.11 |
$241,100 |
D/D |
10,000 |
44,499 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive OfficerOfficer |
|
2011-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,604 |
|
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-02-22 |
4 |
AS |
$8.54 |
$854,060 |
D/D |
(100,000) |
53,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-02-22 |
4 |
OE |
$1.35 |
$135,000 |
D/D |
100,000 |
153,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-02-25 |
4 |
S |
$8.16 |
$489,755 |
D/D |
(60,000) |
53,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-02-25 |
4 |
OE |
$1.35 |
$81,000 |
D/D |
60,000 |
63,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-03-09 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
63,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-04-18 |
4 |
AS |
$15.76 |
$4,728,210 |
D/D |
(300,000) |
63,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-04-18 |
4 |
OE |
$1.35 |
$815,000 |
D/D |
300,000 |
363,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-07-15 |
4 |
OE |
$1.35 |
$6,750 |
D/D |
5,000 |
68,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-08-22 |
4 |
OE |
$1.35 |
$6,750 |
D/D |
5,000 |
73,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2011-11-07 |
4 |
OE |
$1.35 |
$6,750 |
D/D |
5,000 |
78,604 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2012-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
33,333 |
111,937 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2012-07-27 |
4 |
OE |
$1.35 |
$202,500 |
D/D |
150,000 |
261,937 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2012-07-27 |
4 |
AS |
$14.07 |
$2,147,192 |
D/D |
(150,000) |
111,937 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Executive Officer |
|
2012-10-01 |
4 |
AS |
$12.56 |
$1,884,315 |
D/D |
(150,000) |
111,937 |
0 |
- |
|
91 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|